These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 12100181)

  • 1. Clinical characteristics of pruritus in chronic idiopathic urticaria.
    Yosipovitch G; Ansari N; Goon A; Chan YH; Goh CL
    Br J Dermatol; 2002 Jul; 147(1):32-6. PubMed ID: 12100181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of generalized idiopathic pruritus in patients from a tertiary referral center in Singapore.
    T-J Goon A; Yosipovitch G; Chan YH; Goh CL
    Int J Dermatol; 2007 Oct; 46(10):1023-6. PubMed ID: 17910707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus.
    Yosipovitch G; Goon AT; Wee J; Chan YH; Zucker I; Goh CL
    Int J Dermatol; 2002 Apr; 41(4):212-6. PubMed ID: 12031029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis.
    Yosipovitch G; Goon A; Wee J; Chan YH; Goh CL
    Br J Dermatol; 2000 Nov; 143(5):969-73. PubMed ID: 11069504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
    Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
    Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of pruritus characteristics and impact on burn survivors.
    Parnell LK; Nedelec B; Rachelska G; LaSalle L
    J Burn Care Res; 2012; 33(3):407-18. PubMed ID: 22210065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
    Ortonne JP; Grob JJ; Auquier P; Dreyfus I
    Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Aspects of Itch in Lichen Planus.
    Welz-Kubiak K; Reich A; Szepietowski JC
    Acta Derm Venereol; 2017 Apr; 97(4):505-508. PubMed ID: 27826613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone for the management of post-burn pruritus: A preliminary report.
    LaSalle L; Rachelska G; Nedelec B
    Burns; 2008 Sep; 34(6):797-802. PubMed ID: 18325676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation and validation of the Urticaria Patient Daily Diary for adolescents.
    Mathias SD; Tschosik EA; Zazzali JL
    Allergy Asthma Proc; 2012; 33(2):186-90. PubMed ID: 22525396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria.
    Stull D; McBride D; Tian H; Gimenez Arnau A; Maurer M; Marsland A; Balp MM; Khalil S; Grattan C
    Br J Dermatol; 2017 Oct; 177(4):1093-1101. PubMed ID: 28295198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihistamines in the treatment of urticarial disorders.
    Shuster S
    Cutis; 1988 Oct; 42(4A):26-8. PubMed ID: 2903816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H1 antagonists in the management of the itch of urticarias.
    Kobza Black A
    Skin Pharmacol; 1992; 5(1):21-4. PubMed ID: 1349487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo effects on itch: a meta-analysis of clinical trials of patients with dermatological conditions.
    van Laarhoven AIM; van der Sman-Mauriks IM; Donders ART; Pronk MC; van de Kerkhof PCM; Evers AWM
    J Invest Dermatol; 2015 May; 135(5):1234-1243. PubMed ID: 25609025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulating Agents as Antipruritics.
    Erickson S; Nahmias Z; Rosman IS; Kim BS
    Dermatol Clin; 2018 Jul; 36(3):325-334. PubMed ID: 29929604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Tripterygium hypoglaucum Hutch in adults with chronic urticaria.
    Zhong J; Xian D; Xu Y; Liu J
    J Altern Complement Med; 2011 May; 17(5):459-64. PubMed ID: 21568746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and responsiveness of the Urticaria Activity and Impact Measure: A new patient-reported tool.
    Maurer M; Mathias SD; Crosby RD; Rajput Y; Zazzali JL
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):641-647. PubMed ID: 29567359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How stress triggers itch: a preliminary study of the mechanism of stress-induced pruritus using fMRI.
    Kim HJ; Park JB; Lee JH; Kim IH
    Int J Dermatol; 2016 Apr; 55(4):434-42. PubMed ID: 26276021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    Yagami A; Furue M; Togawa M; Saito A; Hide M
    J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.